ARCHIVES

Ilex Oncology Buys Symphar, Controls Drug For Bone Mets.

This article is from The Cancer Letter archive.

Vol. 27 No. 09 | March 2, 2001

Download PDF Visit The Full Archive

Related Articles

Senate Committee Approves Additional $400 Million For NCI, $275 Million For FDA.

May 16, 2008

FDA Ceases Exclusion Of Women From Early Drug Studies

May 7, 1993

House Passes Cancer Bill With Mandates for NCI

September 28, 2012

NCI 1985 Bypass Budget By Groups

May 20, 1983

In Brief: Yarbro To Leave As NCI Centers Chief to Head Missouri Cancer Program; Replaced By Cantril

May 30, 1975

PDF file includes 8-page February issue of Business & Regulatory Report.

February 27, 2004